Beranda › Melanoma › Nebraska › Omaha
Uji klinis Melanoma di Omaha, NE
12 studi untuk Melanoma mencari peserta di lokasi sekitar Omaha (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi jauhnya
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Menerima pesertaFase 3
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Menerima pesertaFase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
- Nebraska Cancer Specialists, Omaha
Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- dan 1 lainnya
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Menerima pesertaFase 1/2
- Nebraska Cancer Specialists, Omaha
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Menerima pesertaFase 3
- TIERING Percentiles, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Omaha
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- University of Nebraska Medical Center, Omaha
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medicine, Omaha
- Nebraska Medicine - Bellevue, Bellevue · 9 mi jauhnya
Uji klinis Melanoma di kota lain
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN33 studi
- Pittsburgh, PA31 studi
- Boston, MA26 studi
- Philadelphia, PA23 studi
- San Francisco, CA22 studi
- Durham, NC21 studi
- Atlanta, GA21 studi
- St. Louis, MO21 studi
- Salt Lake City, UT21 studi
Studi lain di Omaha
- Kanker Prostat27 studi
- Kanker Paru Non-Sel Kecil24 studi
- Kanker Payudara22 studi
- Kanker Kolorektal18 studi
- Kanker (semua jenis)18 studi
- Mieloma Multipel16 studi
- Limfoma Non-Hodgkin14 studi
- Kanker Ovarium14 studi
- Kanker Pankreas14 studi
- Karsinoma Sel Skuamosa Kepala dan Leher13 studi
- Gagal Jantung13 studi
- Kanker Metastatik13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.